Literature DB >> 1476055

Acupuncture and occlusal splint therapy in the treatment of craniomandibular disorders. II. A 1-year follow-up study.

T List1, M Helkimo.   

Abstract

Eighty patients, of whom 22 were men and 58 women, participated in a 1-year follow-up study. All participants in the study showed signs and symptoms of craniomandibular disorders (CMD) and had had pain for more than 6 months at treatment start. The patients were randomly assigned to either acupuncture or occlusal splint therapy. Those patients who did not respond to either of the treatment modes were offered various additional therapies. The result showed that 57% of the patients who received acupuncture and 68% of the patients treated with occlusal splint therapy benefited subjectively (p < 0.01) and clinically (p < 0.001) from the treatment over a 12-month period. No statistically significant difference was found between the two groups as to the assessment variables. Those patients who received various additional therapies after acupuncture and/or occlusal splint therapy responded favorably to additional treatment in only a few instances. The study showed that acupuncture gave positive results similar to those of occlusal splint therapy in patients with primarily myogenic CMD symptoms over a 1-year follow-up period.

Entities:  

Mesh:

Year:  1992        PMID: 1476055     DOI: 10.3109/00016359209012785

Source DB:  PubMed          Journal:  Acta Odontol Scand        ISSN: 0001-6357            Impact factor:   2.331


  8 in total

Review 1.  Efficacy of stabilization splints for the management of patients with masticatory muscle pain: a qualitative systematic review.

Authors:  J C Türp; F Komine; A Hugger
Journal:  Clin Oral Investig       Date:  2004-06-04       Impact factor: 3.573

2.  Laser acupuncture in patients with temporomandibular dysfunction: a randomized controlled trial.

Authors:  Luciano Ambrosio Ferreira; Rodrigo Guerra de Oliveira; Josemar Parreira Guimarães; Antonio Carlos Pires Carvalho; Marcos Vinicius Queiroz De Paula
Journal:  Lasers Med Sci       Date:  2013-02-05       Impact factor: 3.161

3.  The efficacy of acupuncture and decompression splints in the treatment of temporomandibular joint pain-dysfunction syndrome.

Authors:  Mario Vicente-Barrero; Si-Lei Yu-Lu; Bingxin Zhang; Sacramento Bocanegra-Pérez; David Durán-Moreno; Adriana López-Márquez; Milan Knezevic; José-María Castellano-Navarro; José-María Limiñana-Cañal
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-11-01

4.  Ear Acupuncture Therapy for Masticatory Myofascial and Temporomandibular Pain: A Controlled Clinical Trial.

Authors:  Luciano Ambrosio Ferreira; Eduardo Grossmann; Eduardo Januzzi; Rafael Tardin Rosa Ferraz Gonçalves; Fernando Antonio Guedes Mares; Marcos Vinicius Queiroz de Paula; Antonio Carlos Pires Carvalho
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-17       Impact factor: 2.629

5.  Adjacent, distal, or combination of point-selective effects of acupuncture on temporomandibular joint disorders: A randomized, single-blind, assessor-blind controlled trial.

Authors:  Kyung-Won Kang; Woo-Young Kim; Tae-Hun Kim; Byung-Cheul Shin; So-Young Jung; Ae-Ran Kim; Sun-Mi Choi
Journal:  Integr Med Res       Date:  2012-10-16

6.  Acupuncture therapy in the management of the clinical outcomes for temporomandibular disorders: A PRISMA-compliant meta-analysis.

Authors:  Jun-Yi Wu; Chao Zhang; Yang-Peng Xu; Ya-Yu Yu; Le Peng; Wei-Dong Leng; Yu-Ming Niu; Mo-Hong Deng
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

7.  Evaluation of Efficacy of Ultrasonography in the Assessment of Transcutaneous Electrical Nerve Stimulation in Subjects with Myositis and Myofascial Pain.

Authors:  Seema Patil; Asha R Iyengar; Ramya Madhuri Kotni; Subash B V; Revan Kumar Joshi
Journal:  Korean J Pain       Date:  2016-01-04

Review 8.  Temporomandibular Disorders: "Occlusion" Matters!

Authors:  Robert J A M de Kanter; Pasquale G F C M Battistuzzi; Gert-Jan Truin
Journal:  Pain Res Manag       Date:  2018-05-15       Impact factor: 3.037

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.